Purchasing from the 200 most commonly prescribed medications is a well-known strategy for pharmacies. In fact, for many pharmacy professionals, it’s a given. But adhering to just the “Top 200” is costing them money. It’s also limiting their options, which means limiting their patients’ options when a drug shortage hits.

Analyzing purchasing data from over 5,000 pharmacy professionals across the country, SureCost’s latest Smarter Purchasing Report shows significant savings opportunities from purchases outside the Top 200. This blog post explains how much pharmacies can save by taking strategic advantage of the entire market. Then, we’ll explain the benefits beyond your bottom line before outlining a smarter purchasing solution to unlock these savings quickly and easily. Read More >